Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Fresenius Kabi Aktiengesellschaft, commonly referred to as Fresenius Kabi, is a global healthcare company headquartered in Bad Homburg, Germany. Founded in 1999, the company has established itself as a leader in the pharmaceutical and medical technology sectors, focusing on lifesaving medicines and technologies.
Fresenius Kabi operates in over 100 countries, with significant presence in Europe, North America, and Asia. The company’s core offerings include intravenous (IV) drugs, infusion therapies, and clinical nutrition products, all designed to enhance patient care. Notably, Fresenius Kabi is recognised for its commitment to quality and innovation, which has solidified its position in the market.
With a strong emphasis on sustainability and patient safety, Fresenius Kabi continues to achieve notable milestones, contributing significantly to the global healthcare landscape.
+15 vs industry average
Fresenius Kabi Aktiengesellschaft’s score of 55 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Fresenius Kabi Aktiengesellschaft yet.
Fresenius Kabi Aktiengesellschaft, headquartered in Germany (DE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Fresenius SE & Co. KGaA, which may influence its climate commitments and emissions reporting.
As of now, there are no documented reduction targets or climate pledges from Fresenius Kabi. The absence of specific emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy or reporting framework.
Fresenius Kabi's climate commitments may be informed by the broader sustainability initiatives of its parent company, Fresenius SE & Co. KGaA, which has been active in addressing climate change and may have cascading targets or performance metrics that impact Fresenius Kabi's operations. However, without specific data or targets from Fresenius Kabi itself, it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Fresenius Kabi Aktiengesellschaft yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more